Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Lowa State University Research Foundation Inc. currently manages 1 pending office action in the Biotechnology & Pharmaceuticals technology area. The prosecution is limited to 1 distinct examiner and 1 distinct art unit. This indicates a highly focused technical review for the foundation's current patent application. The concentration in 1 distinct art unit suggests that the foundation's research is being evaluated within a specific biological or pharmaceutical sub-discipline.
GANGLE, BRIAN J is the busiest examiner, overseeing 1 pending office action. This examiner handles the foundation's entire current pending workload. With only 1 distinct examiner and 1 pending office action, the foundation's immediate success in the patent office depends on the outcome of this single case. The lack of multiple pending actions suggests a very specific or limited filing activity in this technology area. Practitioners should focus on the individual examiner's history and the specific standards of the assigned art unit. The absence of examiner diversity means that the foundation's current prosecution experience is entirely shaped by a single individual's perspective.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GANGLE, BRIAN J | 1 | 76.7% | +14.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18038032 | BACILLUS SUBTILIS STRAIN WITH STRONG INHIBITION OF ENTEROPATHOGENIC AND FOODBORNE PATHOGENIC BACTERIA | GANGLE, BRIAN J | 44d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18038032 | BACILLUS SUBTILIS STRAIN WITH STRONG INHIBITION OF ENTEROPATHOGENIC AND FOODBORNE PATHOGENIC BACTERIA | GANGLE, BRIAN J | 44d overdue |
| Art Unit | Apps |
|---|---|
| 1645 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18038032 | BACILLUS SUBTILIS STRAIN WITH STRONG INHIBITION OF ENTEROPATHOGENIC AND FOODBORNE PATHOGENIC BACTERIA | GANGLE, BRIAN J | 1645 | §101§102§112 | Final Rejection | 44d overdue | Pending | May 22, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial